MacroGenics Announces Date of Second Quarter 2020 Financial Results Conference Call

Rhea-AI Summary

MacroGenics, Inc. (Nasdaq: MGNX) announced it will release its financial results for Q2 2020 after market hours on July 30, 2020. A conference call to discuss these results and recent corporate developments is scheduled for the same day at 4:30 p.m. ET. Interested participants can join by calling (877) 303-6253 (domestic) or (973) 409-9610 (international) using Conference ID 3236629. The call will be available for replay on the company's website for 30 days.

Rockville, MD, July 23, 2020 (GLOBE NEWSWIRE) --

MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announced that the Company will release its financial results for the second quarter 2020 after the market closes on Thursday, July 30, 2020. MacroGenics will host a conference call to discuss the financial results and recent corporate progress on Thursday, July 30, 2020 at 4:30 p.m. ET. The conference call can be accessed by dialing (877) 303-6253 (domestic) or (973) 409-9610 (international) five minutes prior to the start of the call and providing the Conference ID 3236629.

The listen-only webcast of the conference call can be accessed under "Events & Presentations" in the Investor Relations section of the Company's website at http://ir.macrogenics.com/events.cfm. A recorded replay of the webcast will be available shortly after the conclusion of the call and archived on the Company's website for 30 days following the call.

About MacroGenics, Inc.

MacroGenics is a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer. The Company generates its pipeline of product candidates primarily from its proprietary suite of next-generation antibody-based technology platforms, which have applicability across broad therapeutic domains. For more information, please see the Company's website at www.macrogenics.com. MacroGenics and the MacroGenics logo are trademarks or registered trademarks of MacroGenics, Inc.

Anna Krassowska, Ph.D., Vice President, Investor Relations & Corporate Communications
Jim Karrels, Senior Vice President, CFO
1-301-251-5172, info@macrogenics.com

FAQ

When will MacroGenics release its Q2 2020 financial results?

MacroGenics will release its Q2 2020 financial results on July 30, 2020.

What time is the MacroGenics conference call to discuss financial results?

The conference call is scheduled for 4:30 p.m. ET on July 30, 2020.

How can I listen to the MacroGenics conference call?

You can listen to the conference call by dialing (877) 303-6253 (domestic) or (973) 409-9610 (international) five minutes before the call, using Conference ID 3236629.

Will there be a replay of the MacroGenics conference call?

Yes, a recorded replay of the conference call will be available on the company's website for 30 days after the call.